Justin B. Klee insider trades

Open-market stock purchases and sales by Justin B. Klee, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 6, 2022.

Recent trades

DateStockTradeValue
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMLX Amylyx Pharmaceuticals, IncSold$424K
Feb 2, 2026AMLX Amylyx Pharmaceuticals, IncSold$228K
Jan 16, 2026AMLX Amylyx Pharmaceuticals, IncSold$27.7K
Jan 16, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Jan 15, 2026AMLX Amylyx Pharmaceuticals, IncSold$1.8M
Jan 15, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Jan 6, 2026AMLX Amylyx Pharmaceuticals, IncSold$85.6K

Companies traded

  • AMLX Amylyx Pharmaceuticals, Inc: 18 sales, last Mar 5, 2026

Get free alerts when Justin B. Klee files a new trade →